Trans-Pacific Partnership Will Damage Global Health

Huffington Post: The Trans-Pacific Partnership Is Terrible for Public Health
Rep. Raúl M. Grijalva, co-chair of the Congressional Progressive Caucus, and Peter Maybarduk, director of Public Citizen’s Global Access to Medicines Program

The Trans-Pacific Partnership (TPP) is “a pending trade deal between the U.S. and 11 Asian trading partners. Despite the damage it would do to global health, U.S. officials are advancing special rules that expand drug giants’ power under TPP, blocking generic drug competition that could save the lives of people suffering from cancer, HIV and other diseases. … The TPP is a bad deal for taxpayers, for doctors, and for everyone who believes in corporate transparency. If rammed through Congress via fast-track trade authority, which doesn’t allow Congress to offer any amendments, it will lead to lost jobs and lost lives. The Constitution assigns Congress the responsibility to make trade policy. It’s time to take that responsibility seriously” (4/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.